OL
CPRX

Odyssean LLC’s Catalyst Pharmaceutical CPRX Stock Holding History

Odyssean LLC’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$603K Hold
19,184
– – 0.1% 288
2026
Q1 		$475K Sell
19,184
-12,030
-39% -$287K 0.17% 212
2025
Q4 		$729K Buy
+31,214
New +$695K 0.52% 115

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Odyssean LLC's CPRX Position: Q2 2026 in Review

Odyssean LLC held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2026 at 19,184 shares worth $603K. The position accounts for 0.1% of the portfolio, ranked #288.

Odyssean LLC first reported a position in CPRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $729K in Q4 2025. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Odyssean LLC held 19,184 shares of Catalyst Pharmaceutical worth $603K as of Q2 2026.
  • Odyssean LLC left its Catalyst Pharmaceutical share count unchanged in Q2 2026.
  • Catalyst Pharmaceutical made up 0.1% of Odyssean LLC's portfolio in Q2 2026, its #288 holding.
  • Odyssean LLC first reported a position in Catalyst Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • Odyssean LLC's Catalyst Pharmaceutical position peaked at $729K in Q4 2025.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Odyssean LLC's 13F filing for Q2 2026, filed 14 Aug 2026.